Enhance your practice with CME and tools that focus on the management of neurological conditions.
Recognizing the Signs of TK2 Deficiency
Kaitlin Batley, MD
A Closer Look at the Biology Behind MS Progression
Ethan Meltzer, MD
Navigating Emerging Biomarkers in MS Care
Improving MS Diagnosis and Prognosis with Advanced Imaging and Biomarkers
The Role of B-Cell Depletion in MS Care
David Hafler, MD, FANA, MSc
Precision Medicine for Myasthenia Gravis
Shruti Raja, MD, MHS
Navigating Emerging Treatment Options in MG
Qihua Fan, MD
The New Era of Targeted Therapy for Myasthenia Gravis
Starting With Confidence: A Practical Framework for Amyloid-Targeting Therapy in Early Alzheimer’s Disease
Dani Cabral, MD
Engineering Safer Antithrombotic Strategies for Secondary Stroke Prevention
C. Michael Gibson, MD, MS
Valeria Caso, MD, PhD
Ashkan Shoamanesh, MD
Navigating the Limitations of Current BD Therapies
Jose M. Rubio, MD, PhD
Sunny X. Tang, MD
Recurrence as the Rule: BD Symptoms Persist and Cycle
Uncovering TK2d: How to Navigate Diagnostic Challenges
Exploring Genetic Links Between EBV Clearance and MS Risk
Immunologic Phenotyping: The Future of Personalized MG Care
New Therapies, New Strategy: Rethinking MG Inpatient Care
Reimagining Alzheimer's Care: The Advent of Subcutaneous Administration of Anti-Amyloid Therapy
R. Scott Turner, MD, PhD
Outcome Measures Capture Progression in Late-Onset TK2d
More Than a Myopathy: The Lived Experience of TK2d
Untreated Thymidine Kinase 2 Deficiency: Mapping the Progressive Disease Course
Ryan Quigley
Loading...
We're glad to see you're enjoying Global Neurology Academy… but how about a more personalized experience?
Press cancel to remain on Global Neurology Academy. Press the link below or the continue button to keep going.